AALLOX — Seed · €9.4M
ALLOX is a spin-off of the Centre for Genomic Regulation (CRG) that builds a platform for finding allosteric drug targets. It closed a seed round of $10.5M (€9.4M) led by Asabys through its Sabadell Asabys II fund, with CDTI (through SICC Innvierte) and the Institut Català de Finances. It also named Morten Graugaard as chairman.
LeadAsabys Partners (Sabadell Asabys II)
RoundSeed
Announced29 Oct 2026 · as ALLOX (Allostery Exploration Technologies)
CityBarcelona
SectorHealthtech & Bio · Biotech / AI drug discovery
Source
L
C
L
C
